# Myosana Therapeutics, Inc. — Form C (Regulation Crowdfunding)

Myosana Therapeutics, Inc. of Seattle, WA filed a Form C (Regulation Crowdfunding) with the SEC on 2025-11-13. Target raise $50K, up to $1.2M. Offered through Wefunder Portal LLC.

## Offering

- Filed: 2025-11-13
- Form: C
- Accession: 0001955277-25-000002
- Target amount: $50K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 50,000
- Price: $1.0000
- Deadline: 2026-04-30
- Funding portal / intermediary: Wefunder Portal LLC
- Intermediary file number: 007-00033
- Intermediary CRD: 283503

## Issuer

- CIK: 0001955277
- Website: https://myosanatherapeutics.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2018-07-17
- Address: 8502 30th Ave. NW, Seattle, WA, 98117
- Employees: 0

## Financials (as filed)

- Total assets (most recent): $2.2M
- Cash (most recent): $695K
- Net income (most recent): $-1.6M
- Net income (prior): $-1.4M
- Short-term debt: $106K

## People (3)

| Name | Role | Location |
| --- | --- | --- |
| Stanley Froehner | CFO, Chairman and Co-Founder | Seattle, WA |
| Matthew Lumley | Board Director | Seattle, WA |
| Nicholas Whitehead | CEO, Co-Founder and CSO | Seattle, WA |

## Reg CF filing history (2)

| Filed | Form | Target | Max |
| --- | --- | --- | --- |
| [2026-04-28](https://search.stillhousedata.com/formc/0001955277-26-000001) | C/A | $50K | $1.2M |

## More

- [CIK 1955277 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1955277&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001955277-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.